Annals of the New York Academy of Sciences

Full citation: Pharmaceutical Science to Improve the Human Condition: Prix Galien 2010. Special issue, Ann N Y Acad Sci. 2011 Mar;1222(1); 1-99.

•Best Medical Technology: Luminex Corporation, xTAG™

Krunic. N, Merante. F, Yaghoubian. S, Himsworth. D, Janeczko. R, “Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel”, Annals of the New York Academy of Sciences, March 2011, DOI: 10.1111/j.1749-6632.2011.05964.x

http://doi.wiley.com/10.1111/j.1749-6632.2011.05964.x.

•Best Biotechnology Product: Merck & Co, Inc, RotaTeq™

Goveia. M, Ciarlet. M, Owen. K, Ranucci. C, “Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine”, Annals of the New York Academy of Sciences, March 2011 DOI: 10.1111/j.1749-6632.2011.05970.x

http://doi.wiley.com/10.1111/j.1749-6632.2011.05970.x.

•Best Pharmaceutical Agent: Novartis, Coartem™

Lefèvre. G, Marrast. A, Grueninger. H, “Novartis Malaria Initiative: best practice example of pharmaceutical industry’s engagement in the fight against malaria”, Annals of the New York Academy of Sciences, March 2011, DOI: 10.1111/j.1749-6632.2011.05973.x

http://doi.wiley.com/10.1111/j.1749-6632.2011.05973.x

Prix Galien International Awardees 

•Amgen, Nplate™

Graham Molineux, “The development of romiplostim for patients with immune thrombocytopenia,” Annals of the New York Academy of Sciences, March 2011, DOI: 10.1111/j.1749-6632.2011.05975.x

http://doi.wiley.com/10.1111/j.1749-6632.2011.05975.x

•Bayer Schering Pharma, Xarelto™

Misselwitz. F, Berkowitz. S, Perzborn. E, “The discovery and development of rivaroxaban”, Annals of the New York Academy of Sciences, March 2011, DOI: 10.1111/j.1749-6632.2011.05971.x

http://doi.wiley.com/10.1111/j.1749-6632.2011.05971.x

Pro Bono Humanitarian Awardees

•Philippe Douste-Blazy, President of UNITAID
•William J. Clinton, President of the Clinton Health Access Initiative

About the Prix Galien:
The Prix Galien is a movement with a mandate to foster, recognize, and reward excellence in scientific innovation aimed at improving the state of human health. Building on a stellar committee of Nobel laureates, the Prix Galien manages an independent, cross-functional, and geographically diverse program of events and sponsorships to brand the “the best of the best” in new medicines and diagnostics.

http://www.prixgalien.com

About Annals of the New York Academy of Sciences:
Annals of the New York Academy of Sciences is one of the oldest scientific journals in the United States and among the most cited of multidisciplinary scientific serials. Continuously published since 1823, Annals is the premier publication of the Academy, offering the proceedings of conferences sponsored by Academy as well as those of other scientific organizations. With 32 volumes published annually, Annals provides multidisciplinary perspectives on research of current scientific interest with far-reaching implications for the wider scientific community and society at large.
To view and download the latest papers from this journal visit: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1749-6632